We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

71 hedge funds and large institutions have $767M invested in Legend Biotech in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

16% more funds holding

Funds holding: 61 → 71 (+10)

6% more capital invested

Capital invested by funds: $723M → $767M (+$43.8M)

0.36% more ownership

Funds ownership: 9.65% → 10.01% (+0.36%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

69% less call options, than puts

Call options by funds: $263K | Put options by funds: $836K

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
22
Increased
20
Reduced
13
Closed
12
Calls
$263K
Puts
$836K
Net Calls
-$573K
Net Calls Change
-$573K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$44.7M
2
CCM
Consonance Capital Management
New York
+$24.5M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$24.3M
4
Artisan Partners
Artisan Partners
Wisconsin
+$23M
5
MWNA
Marshall Wace North America
New York
+$11.2M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$67.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$19.1M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.4M
5
WP
Woodline Partners
California
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIS
26
Capital International Sarl
California
$5.01M -$3.32M -121,594 -41%
Jane Street
27
Jane Street
New York
$3.75M +$3.53M +129,302 New
Canada Pension Plan Investment Board
28
Canada Pension Plan Investment Board
Ontario, Canada
$3.65M +$3.43M +125,900 New
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$3.6M -$12.4M -455,548 -79%
BBA
30
Baker Bros. Advisors
New York
$3.35M – – –
State Street
31
State Street
Massachusetts
$2.63M +$235K +8,630 +11%
ACH
32
ArrowMark Colorado Holdings
Colorado
$2.55M -$2.95M -108,035 -55%
VIA
33
Vident Investment Advisory
Georgia
$1.96M +$63.5K +2,327 +4%
JP Morgan Chase
34
JP Morgan Chase
New York
$1.89M +$669K +24,519 +60%
KBC Group
35
KBC Group
Belgium
$1.58M +$294K +10,770 +25%
Morgan Stanley
36
Morgan Stanley
New York
$1.38M -$1.8M -65,919 -58%
Voloridge Investment Management
37
Voloridge Investment Management
Florida
$1.31M +$1.23M +45,269 New
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.26M -$141K -5,164 -11%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$1.07M +$851K +31,199 +538%
Marshall Wace
40
Marshall Wace
United Kingdom
$686K +$644K +23,622 New
JG
41
Jefferies Group
New York
$609K +$573K +21,000 New
AA
42
AlphaCentric Advisors
Puerto Rico
$580K +$546K +20,000 New
Geode Capital Management
43
Geode Capital Management
Massachusetts
$499K – – –
Millennium Management
44
Millennium Management
New York
$498K +$468K +17,174 New
CS
45
Credit Suisse
Switzerland
$478K +$90.5K +3,318 +25%
PAMI
46
Perseverance Asset Management International
Cayman Islands
$449K +$422K +15,488 New
AI
47
Atom Investors
Texas
$445K +$418K +15,339 New
UOC
48
UBS O'Connor
Illinois
$435K +$409K +15,000 New
CF
49
CNA Financial
Illinois
$364K +$141K +5,160 +70%
SAM
50
Sectoral Asset Management
Quebec, Canada
$299K +$281K +10,300 New
1
2
3 4

LEGN Hedge Fund Activity: Q1 2021 in Review

71 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q1 2021, worth a combined $767M — up 6.1% from $723M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LEGN positions and 12 closed out — a net gain of 10 holders — while 20 added to existing stakes and 13 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $44.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $67.8M sold.

  • 71 institutional investors held Legend Biotech (LEGN) as of Q1 2021, up from 61 in Q4 2020.
  • Funds reported $767M of Legend Biotech stock for Q1 2021, up 6.1% quarter-over-quarter.
  • 22 funds opened new Legend Biotech positions in Q1 2021 and 12 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q1 2021 was Point72 Asset Management, an estimated $44.7M added.
  • The largest Legend Biotech seller in Q1 2021 was RA Capital Management, an estimated $67.8M sold.

Based on aggregated 13F filings for Q1 2021.